Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2025-12-25 @ 2:08 AM
NCT ID: NCT03133260
Eligibility Criteria: Inclusion Criteria: * Patients of both genders over 45 years scheduled for non-urgent surgery with in-hospital stay of 24 hours minimum who require general and or regional anaesthesia (epidural or subarachnoidal) that have signed the inform consent who will be operated of: 1\. High-risk surgery: * Open abdominal aortic aneurism repair * Major vascular surgery * Major amputations * Carotid endarterectomy * Duodeno-pancreatic surgery * Hepatic resection or resection of biliary duct * Esophagectomy * Suprarenal resection * Cystectomy * Pneumonectomy 2\. Medium risk-surgery with cardiovascular risk factors (see below): * Intraperitoneal surgery (rectum, colon, small bowel, gastric surgery) * Peripherical angioplasty * Endovascular aneurism repair * Head and neck surgery * Major orthopedic surgery (hip, knee, column) * Major urological or gynecological surgery * Thoracic surgery (lobectomy or atypical pulmonary resections) a) With 1 risk factor: * History of coronary artery disease * History of cerebrovascular disease (history of transient ischemic attack or stroke) * History of congestive heart failure * History of vascular disease b) With 2 risk factors: * Diabetes mellitus with medical treatment * Renal disease (FGE \< 45 ml•min-1•1.73m2 ) * Functional capacity \< 4METs * Intraoperative blood loss \>600ml Exclusion Criteria: * Patients without consent information * Patients non included in the inclusion criteria
Sex: ALL
Minimum Age: 45 Years
Study: NCT03133260
Study Brief:
Protocol Section: NCT03133260